Simposi


Type 2 Diabetes: Glycemic Control and Innovation Therapy

Thursday, October 26th / 12.30-13.00
120 A new combination therapy for type 2 Diabetes: Basal insulin plus GLP-1 receptor agonists,from phisiophatology to sinergy of actions
Giovambattista De Sarro
141 Glycemic control in type 2 Diabetes: clinical benefit and barriers to insulin intensification
Giorgio Sesti